Your browser doesn't support javascript.
loading
Current evidence and clinical relevance of drug-microbiota interactions in inflammatory bowel disease.
Becker, Heike E F; Demers, Karlijn; Derijks, Luc J J; Jonkers, Daisy M A E; Penders, John.
Affiliation
  • Becker HEF; Division Gastroenterology-Hepatology, Department of Internal Medicine, NUTRIM School of Translational Research in Metabolism, Maastricht University Medical Centre+, Maastricht, Netherlands.
  • Demers K; Department of Medical Microbiology, Infectious Diseases and Infection Prevention, NUTRIM School of Translational Research in Metabolism, Maastricht University Medical Centre+, Maastricht, Netherlands.
  • Derijks LJJ; Division Gastroenterology-Hepatology, Department of Internal Medicine, NUTRIM School of Translational Research in Metabolism, Maastricht University Medical Centre+, Maastricht, Netherlands.
  • Jonkers DMAE; Department of Clinical Pharmacy and Pharmacology, Máxima Medical Center, Veldhoven, Netherlands.
  • Penders J; Department of Clinical Pharmacy and Toxicology, Maastricht University Medical Centre+, Maastricht, Netherlands.
Front Microbiol ; 14: 1107976, 2023.
Article in En | MEDLINE | ID: mdl-36910207
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Front Microbiol Year: 2023 Document type: Article Affiliation country: Países Bajos Country of publication: Suiza
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Front Microbiol Year: 2023 Document type: Article Affiliation country: Países Bajos Country of publication: Suiza